Hypertrophic cardiomyopathy in a lupus patient: a case of hydroxychloroquine cardiotoxicity
- PMID: 31493341
- PMCID: PMC6989295
- DOI: 10.1002/ehf2.12508
Hypertrophic cardiomyopathy in a lupus patient: a case of hydroxychloroquine cardiotoxicity
Abstract
Hydroxychloroquine (HCQ) is a well-established and effective immunomodulatory therapy for systemic lupus erythematosus and other autoimmune diseases. While retinal toxicity is a well-recognized complication, cardiotoxicity is lesser known. This case consists of a 63-year-old Filipina on chronic HCQ treatment that led to severe biventricular hypertrophy, increased filling pressure, systemic and pulmonary hypertension, and elevated brain natriuretic peptide. Genetic testing ruled out lysosomal storage disorders but revealed five rare variants of uncertain significance, including one that was temporarily re-classified as likely pathogenic. Endomyocardial biopsy demonstrated myeloid bodies admixed with curvilinear bodies, most consistent with a diagnosis of HCQ toxicity. This case illustrates the importance of clinical integration of multiple causes of cardiomyopathy, recognition of HCQ cardiotoxicity, and increased uncertainty in genetic test findings among racial minorities.
Keywords: Hydroxychloroquine; Hypertrophic cardiomyopathy; Minority; Myeloid bodies; Variant of uncertain significance.
Conflict of interest statement
None declared.
Figures
References
-
- Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF. American Academy of O. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision). Ophthalmology 2016; 123: 1386–1394. - PubMed
-
- Costedoat‐Chalumeau N, Hulot JS, Amoura Z, Delcourt A, Maisonobe T, Dorent R, Bonnet N, Sablé R, Lechat P, Wechsler B, Piette JC. Cardiomyopathy related to antimalarial therapy with illustrative case report. Cardiology 2007; 107: 73–80. - PubMed
-
- Authors/Task Force members , Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733–2779. - PubMed
-
- Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long‐term hydroxychloroquine therapy. JAMA Ophthalmol 2014; 132: 1453–1460. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
